コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 with BK viremia and was not associated with hemorrhagic cystitis.
2 Haufen was not significantly correlated with hemorrhagic cystitis.
3 eteral stenosis, interstitial nephritis, and hemorrhagic cystitis.
4 cyclophosphamide to reduce the incidence of hemorrhagic cystitis.
5 ost completely prevent CP-induced ulcerative hemorrhagic cystitis.
6 failing immune control and BKPyV-associated hemorrhagic cystitis.
7 ransient delays in immune-reconstitution and hemorrhagic cystitis.
8 cally targeted to prevent ifosfamide-induced hemorrhagic cystitis.
9 new therapeutic target for the treatment of hemorrhagic cystitis.
10 ent-related complications included transient hemorrhagic cystitis (1 patient), vaginal bleeding (2 pa
12 inal hemorrhage, 6.4% had moderate or severe hemorrhagic cystitis, 2.8% had pulmonary hemorrhage, and
13 de and other oxazaphosphorines can result in hemorrhagic cystitis, a constellation of complications c
14 virus (BKPyV) is associated with symptomatic hemorrhagic cystitis after hematopoietic cell transplant
16 n (HCT), polyoma-BK virus is associated with hemorrhagic cystitis and also with polyomavirus nephropa
20 idney transplant patients and BKV-associated hemorrhagic cystitis (BKV-HC) in allogeneic hematopoieti
22 ects), microscopic urinalysis for hematuria (hemorrhagic cystitis, bladder cancer), ECG (anthracyclin
24 en of 14 patients treated for BKV-associated hemorrhagic cystitis experienced complete resolution of
25 MT) recipients, are associated not only with hemorrhagic cystitis (HC) but also with hepatitis, conju
26 ne the association of BK plasma viremia with hemorrhagic cystitis (HC) in hematopoietic cell transpla
29 nephropathy in renal transplant patients and hemorrhagic cystitis in bone marrow transplant patients.
30 ral stenosis in renal transplant patients or hemorrhagic cystitis in bone marrow transplant recipient
32 re 27 patients who experienced grades 2 to 3 hemorrhagic cystitis, only 1 of whom had received contin
34 o significant differences were identified in hemorrhagic cystitis or in the PROMIS subscales between
36 2 or its ligands may have increased risks of hemorrhagic cystitis or urothelial cancer from persisten
37 r discharge, the patient was readmitted with hemorrhagic cystitis, persistent thrombocytopenia, and b
38 of BK viremia (range, 0-1.0 x 10 copies/mL), hemorrhagic cystitis (present/absent), and data on kidne
40 role satisfaction) as primary end points and hemorrhagic cystitis symptoms and Lee subscales as secon